by Natasha Davie | Oct 17, 2012
It has taken just six years since the release of his seminal publication on the genetic reprogramming of human somatic cells for Shinya Yamanaka to be awarded the most prestigious of all accolades: the Nobel Prize. Compare that to his co-recipient, Sir John B. Gurdon,...
by Angela C. H. McDonald | Oct 16, 2012
I periodically indulge myself in the personal lives of the Seattle Grace Hospital staff on Grey’s Anatomy. I am particularly fond of the character Dr. Addison Montgomery, world-class neo-natal surgeon. After enduring some juicy relationship drama, Addison decides to...
by Paul Krzyzanowski | Sep 20, 2012
[pullquote]How will Romney’s opinion change in light of papers, which describe healthy mice being created from iPS cells?[/pullquote]As 2012 slowly creeps on we can finally see November’s Presidential Election in the United States on the horizon marking the end of a...
by Angela C. H. McDonald | Sep 11, 2012
You don’t have to follow pharmaceutical industry news to know that this summer has been a disappointing one for Alzheimer’s research. Many major media outlets covered the failure of potential Alzheimer’s drug bapineuzumab (Pfizer/Johnson & Johnson) in Phase II/III...
by Angela C. H. McDonald | Aug 30, 2012
If you tuned into the evening news on Monday night (at least here in Canada), you would have seen my PhD supervisor Janet Rossant, discussing a recent advancement in stem cell differentiation. Amy Wong, post-doctoral fellow in the Rossant lab, created a protocol for...
by Angela C. H. McDonald | Aug 13, 2012
It takes precision, focus and persistence to perfect the art of origami. So perhaps it is no accident that researchers have needed to apply the same skills to overcome challenges in siRNA delivery, right down to the folding. A couple of years ago, my fellow blogger...
Comments